Vapotherm, Redwire, and These 2 Penny Stocks Insiders Are Aggressively Buying – Pardes Biosciences (NASDAQ:PRDS), Isoray (AMEX:ISR)

The Dow Jones closed down nearly 500 points on Monday. Meanwhile, investors focused on some notable insider trades.

When insiders buy or sell shares, it reflects their belief in or concern for the company’s prospects. Investors and traders interested in penny stocks may consider this as a factor in their overall investment or trading decision.

Below is a look at some notable recent insider trading for penny stocks. For more, see Benzinga’s insider trading platform.

Isoray

  • Business: Isoray, Inc. ISR CFO Jonathan Hunt Total bought 85,404 shares At an average price of $0.38. About 32.5 thousand dollars were spent in acquiring these shares.
  • What is happening: The company said last month that revenue for the first quarter of fiscal 2023 would drop 33% to $1.72 million.
  • What Isoray does: Isore, Inc., based in Richland, Washington, develops, manufactures, sells and markets isotope-based medical products and devices for the treatment of cancer and other fatal diseases in the United States and internationally.

redwire

  • Business, Redwire Corporation RDW director john bolton Total 9,023 shares acquired At an average price of $2.01. The insider spent approximately $18.14 thousand to purchase these shares.
  • What is happening: The company said last month that revenue rose 14.0% to $37.2 million for the three months ended September 30, 2022.
  • what does redwire doRedwire Corporation, headquartered in Jacksonville, Florida, is a space infrastructure company.

Investor sentiment falls amid concerns about further Fed rate hikes

don’t forget to check out our premarket coverage here ,

Vapotherm

  • Business, Vapotherm, Inc. Wapo SVP and Chief Technology Officer Brian Lawrence Total 100,000 shares acquired At an average price of $1.33. About $ 132.95 thousand was spent in acquiring these shares.
  • What is happening: Vapotherm, last month, reported worse-than-expected third-quarter results.
  • what does vapotherm doVapotherm, founded in 1993, is a medical technology company.

Pardes Biosciences

  • Business, Pardes Biosciences, Inc. PRDS 10% owner Foresight Capital Fund V, L.P. Total acquired 637,420 shares At an average price of $0.85. The insider spent $541.81 thousand to buy these shares.
  • What is happeningLast month, Pardes Biosciences reported a third quarter loss of $0.40 per share.
  • What does Pardes Biosciences do: Pardes Biosciences, incorporated in 2020, is a clinical stage biopharmaceutical company.

Source link

Leave a Comment